Flora Growth Corp. (FLGC)
USD 0.46
(0.65%)
USD 0.46
(0.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -50.35 Million USD | -362.47% |
| 2022 | 3.29 Million USD | 117.38% |
| 2021 | -18.95 Million USD | -53.62% |
| 2020 | -12.33 Million USD | -337.68% |
| 2019 | -2.81 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.86 Million USD | -233.53% |
| 2024 Q1 | -859 Thousand USD | 68.08% |
| 2023 Q1 | -3.04 Million USD | -113.62% |
| 2023 FY | -8.64 Million USD | -362.47% |
| 2023 Q4 | -2.69 Million USD | -398.33% |
| 2023 Q3 | -540 Thousand USD | 98.65% |
| 2023 Q2 | -40.06 Million USD | -1214.34% |
| 2022 Q2 | -7.04 Million USD | 8.0% |
| 2022 FY | 3.29 Million USD | 117.38% |
| 2022 Q1 | -7.66 Million USD | 24.8% |
| 2022 Q4 | 22.37 Million USD | 611.29% |
| 2022 Q3 | -4.37 Million USD | 37.9% |
| 2021 FY | -18.95 Million USD | -53.62% |
| 2021 Q1 | -2.57 Million USD | 48.25% |
| 2021 Q4 | -10.18 Million USD | -182.03% |
| 2021 Q3 | -3.61 Million USD | -22.98% |
| 2021 Q2 | -2.93 Million USD | -14.01% |
| 2020 Q3 | -4.97 Million USD | -199.52% |
| 2020 Q2 | -1.66 Million USD | -162.43% |
| 2020 FY | -12.33 Million USD | -337.68% |
| 2020 Q1 | -633.31 Thousand USD | 0.0% |
| 2020 Q4 | -4.97 Million USD | 0.0% |
| 2019 Q2 | -1.89 Million USD | 0.0% |
| 2019 FY | -2.81 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 130.159% |
| Embecta Corp. | 221.5 Million USD | 122.733% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 207.202% |
| Dynavax Technologies Corporation | -37.02 Million USD | -35.989% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 67.631% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 157.433% |
| PainReform Ltd. | -9.58 Million USD | -425.396% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -233.426% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -952.264% |
| SCYNEXIS, Inc. | 72.66 Million USD | 169.292% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -1901.974% |
| Cosmos Health Inc. | -21.83 Million USD | -130.651% |
| Journey Medical Corporation | -2.07 Million USD | -2329.04% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -952.264% |
| Safety Shot Inc | -12.18 Million USD | -313.275% |
| Alpha Teknova, Inc. | -35.56 Million USD | -41.591% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 68.407% |
| Bright Green Corporation | -8.89 Million USD | -466.324% |
| Procaps Group, S.A. | 38.97 Million USD | 229.202% |
| Theratechnologies Inc. | -10.62 Million USD | -373.831% |
| Harrow Health, Inc. | 580 Thousand USD | 8781.724% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -971.134% |
| Biofrontera Inc. | -22.67 Million USD | -122.049% |
| DURECT Corporation | -36.88 Million USD | -36.52% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -855.665% |
| Cronos Group Inc. | -81.37 Million USD | 38.121% |
| OptiNose, Inc. | -22.74 Million USD | -121.356% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 124.089% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | -28.608% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 498.623% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 502.028% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -1061.216% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -710.747% |
| Radius Health, Inc. | -3.92 Million USD | -1182.904% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -1327.764% |
| ProPhase Labs, Inc. | -21.61 Million USD | -132.98% |
| Phibro Animal Health Corporation | 53.31 Million USD | 194.446% |
| Procaps Group S.A. | 52.32 Million USD | 196.235% |
| Alvotech | -354.86 Million USD | 85.81% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -490.801% |
| Viatris Inc. | 766.2 Million USD | 106.572% |
| Rockwell Medical, Inc. | -6.67 Million USD | -654.933% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -858.394% |
| SIGA Technologies, Inc. | 83.62 Million USD | 160.217% |
| Tilray Brands, Inc. | -174.74 Million USD | 71.184% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 639.642% |
| Shineco, Inc. | -17.06 Million USD | -195.057% |
| PetIQ, Inc. | 60.01 Million USD | 183.902% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -963.055% |
| Incannex Healthcare Limited | -30.04 Million USD | -67.618% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 120.069% |
| Alimera Sciences, Inc. | -1.47 Million USD | -3323.114% |
| Silver Spike Investment Corp. | 7.34 Million USD | 786.012% |
| Assertio Holdings, Inc. | -243.53 Million USD | 79.324% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -754.561% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -269.778% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -222.906% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -151.141% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 63.472% |
| Hempacco Co., Inc. | -8.81 Million USD | -471.407% |
| Talphera, Inc. | -16.88 Million USD | -198.147% |
| Alvotech | -354.86 Million USD | 85.81% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 194.201% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 113.809% |
| Currenc Group, Inc. | -6.64 Million USD | -657.683% |
| Kamada Ltd. | 10.06 Million USD | 600.338% |
| Indivior PLC | -4 Million USD | -1158.85% |
| Evoke Pharma, Inc. | -7.43 Million USD | -577.631% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -151.141% |
| Evolus, Inc. | -49.23 Million USD | -2.277% |
| HUTCHMED (China) Limited | 18.37 Million USD | 374.035% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 125.562% |
| Akanda Corp. | -10.05 Million USD | -400.966% |